News | June 03, 2026
Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The conference highlighted research suggesting that deuterium levels may influence key biological processes
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
